Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesVitrolife AB

Vitrolife AB

PortfolioPortfolio WatchlistWatchlist
Company price
None GBX 0.00(0%)
Last update at 2026-10-28T03:28:52.038901Z
Market Cap
52418.06M

Momentum Score

…

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
84.75
Low
161.65
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Vitrolife AB develops and supplies products and services for assisted reproductive technologies, including laboratory consumables and clinical equipment used by fertility clinics. Longer-term growth may be supported by rising demand for fertility treatments, expanding access in emerging markets, and ongoing product development that drives recurring consumable sales.

Key risks include regulatory or reimbursement changes, competitive pressure from larger diagnostics and device companies, execution risk in geographic expansion, and sensitivity to clinic capital spending and currency fluctuations.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
110.20
Dividend Yield
0.37%
Revenue TTM
3440.00M
Revenue Per Share
25.40
Gross Profit TTM
1997.00M
Debt / Equity
0.21
ROE
-46.55%
Net Debt
868.00M
ROCE
-46.01%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -4886.00M 674.00M -3712.00M 537.00M 460.00M
Net income -5013.00M 513.00M -3851.00M 394.00M 341.00M
Selling general administrative - 478.00M 433.00M 400.00M 259.00M
Selling and marketing expenses - 754.00M 684.00M 602.00M 244.00M
Gross profit 1750.00M 2139.00M 1978.00M 1780.00M 1046.00M
Ebit -4835.00M 341.00M -3610.00M 647.00M 429.00M
Ebitda -4408.00M 783.00M -3185.00M 991.00M 506.00M
Depreciation and amortization 427.00M 442.00M 425.00M 344.00M 77.00M
Operating income 616.00M 783.00M -3589.00M 647.00M 429.00M
Other operating expenses 2824.00M 2826.00M 7101.00M 2655.00M 1212.00M
Interest expense 51.00M 109.00M 102.00M - 0.00M
Income tax expense 127.00M 160.00M 139.00M 143.00M 116.00M
Total revenue 3440.00M 3609.00M 3512.00M 3234.00M 1681.00M
Total operating expenses 1134.00M 1356.00M 5567.00M 1201.00M 577.00M
Cost of revenue 1690.00M 1470.00M 1534.00M 1454.00M 635.00M
Total other income expense net -5502.00M -109.00M -123.00M -110.00M 31.00M
Net income applicable to common shares - - - 394.00M 340.97M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 11124.00M 17446.00M 16329.00M 20551.00M 19429.00M
Intangible assets 3835.00M 4342.00M 4253.00M 4603.00M 4494.00M
Other current assets 74.00M 33.00M 137.00M 135.00M 73.00M
Total liab 3229.00M 3805.00M 3606.00M 3811.00M 4088.00M
Total stockholder equity 7894.00M 13639.00M 12722.00M 16736.00M 15322.00M
Deferred long term liab - - - - 58.44M
Other current liab 364.00M 316.00M 168.00M 440.00M 781.00M
Common stock 28.00M 28.00M 28.00M 28.00M 28.00M
Retained earnings -6754.00M -1608.00M -1993.00M 2000.00M 1730.00M
Other liab - - - 1147.00M 1106.78M
Good will 4443.00M 10121.00M 9591.00M 13874.00M 12995.00M
Other assets - - - 184.00M 200.00M
Cash 809.00M 1135.00M 861.00M 578.00M 630.00M
Total current liabilities 615.00M 705.00M 557.00M 621.00M 954.00M
Current deferred revenue - - 52.00M - -
Net debt 868.00M 954.00M 1228.00M -578.00M -630.00M
Short term debt 43.00M 160.00M 147.00M - -
Short long term debt total 1677.00M 2089.00M 2089.00M - -
Other stockholder equity 13543.00M 13543.00M 13544.00M 14708.00M 13564.00M
Property plant equipment - - - 318.00M 332.97M
Total current assets 2092.00M 2357.00M 1914.00M 1572.00M 1407.00M
Net tangible assets - - - - -2166.91M
Net receivables 796.00M 767.00M 503.00M 454.00M 391.00M
Inventory 413.00M 422.00M 413.00M 405.00M 313.00M
Accounts payable 208.00M 203.00M 171.00M 181.00M 173.00M
Accumulated other comprehensive income 1077.00M 1675.00M 1143.00M - -
Non currrent assets other - 54.00M 111.00M -18795.00M -17822.00M
Non current assets total 9032.00M 15089.00M 14415.00M 18795.00M 17822.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - - 15.85M
Change to liabilities - - - -48.00M 0.00M
Total cashflows from investing activities -302.00M -377.00M -124.00M -144.00M -6518.49M
Net borrowings - - - -460.00M 2334.91M
Total cash from financing activities -553.00M -286.00M -300.00M -582.00M 5749.00M
Change to operating activities - - - - 42.23M
Net income -5013.00M 513.00M -3851.00M 394.00M 341.00M
Change in cash -326.00M 274.00M 283.00M -52.00M -343.57M
Begin period cash flow 1135.00M 861.00M 578.00M 630.00M 973.57M
End period cash flow 809.00M 1135.00M 861.00M 578.00M 630.00M
Total cash from operating activities 635.00M 907.00M 757.00M 636.00M 384.00M
Depreciation 427.00M - 425.00M 374.00M 95.00M
Other cashflows from investing activities -32.00M -202.00M -47.00M - -
Dividends paid 149.00M 135.00M 115.00M 109.00M 87.00M
Change to inventory -20.00M 2.00M -15.00M -71.00M -47.00M
Change to account receivables -148.00M -174.00M -95.00M -56.00M -5.00M
Sale purchase of stock - - - - -23.00M
Other cashflows from financing activities -47.00M -47.00M -31.00M 5.00M 5878.00M
Change to netincome - - - - -55.37M
Capital expenditures 270.00M 92.00M 119.00M 51.00M 25.00M
Change in working capital -96.00M -68.00M -119.00M -127.00M -52.00M
Stock based compensation - - 17.00M 10.00M 5.00M
Other non cash items 5317.00M 462.00M 4285.00M -15.00M -5.00M
Free cash flow 365.00M 907.00M 638.00M 585.00M 359.00M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

Gustaf Werners gata 2, Gothenburg, Sweden, 421 32

46 31 721 80 00

https://www.vitrolife.com

1151

Name Title Year Born
Mr. Thomas Axelsson M.Sc. Pres & CEO 1959
Mr. Patrik Tolf Chief Financial Officer 1970
Mr. Claus Bisgaard Sr. VP of Technologies 1977
Mr. Rickard Ericsson Sr. VP of Global Sales & Marketing 1971
Ms. Karin Koritz Russberg Sr. VP of HR & Sustainability 1969
Ms. Daniel Forss Sr. VP of Consumables 1972
Ricardo Capella Sr. VP Genetic Services 1968
Ms. Bronwyn Brophy O´Connor CEO & President 1974
Mr. Par Ihrskog Chief Financial Officer 1971
Mr. Ermanno Sironi Chief Operating Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…